Back
Nautilus Biotechnology, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
56
NAUT
Nautilus Biotechnology, Inc.
Last Price:
$2.06
Seasonality Move:
-17.65%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atNautilus Biotechnology, Inc. Stock Forecast
-
Is Nautilus Biotechnology, Inc. Stock Undervalued?The current Nautilus Biotechnology, Inc. [NAUT] share price is $2.06. The Score for NAUT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
NAUT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Nautilus Biotechnology, Inc. Stock Go Up Next Year?
Data Unavailable
Nautilus Biotechnology, Inc. Stock Rating
Data Unavailable
Nautilus Biotechnology, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
nautilus.bio
52-Week Data
52-Week High:
2.54
52-Week Low:
0.62
Prediction Charts
Market Cap:
260.2M
Price in USD:
2.06
Volume:
348.7K
Beta:
1.52
Technical Analysis
SMA50:
1.91
SMA100:
1.37
SMA200:
1.07
52-Wk Change:
13.19%
Stock Predictions
-
Is Nautilus Biotechnology, Inc. stock public?Yes, Nautilus Biotechnology, Inc. is a publicly traded company.
-
What is the Nautilus Biotechnology, Inc. stock quote today?The Nautilus Biotechnology, Inc. stock price is 2.06 USD today.
-
How to buy Nautilus Biotechnology, Inc. stock online?You can buy Nautilus Biotechnology, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-18 | 1.89 | 1.94 | 2.12 | 1.86 |
| Dec-19 | 1.98 | 1.94 | 1.98 | 1.87 |
| Dec-22 | 1.94 | 1.98 | 2.03 | 1.93 |
| Dec-23 | 1.98 | 1.95 | 1.98 | 1.91 |
| Dec-24 | 1.95 | 2.00 | 2.00 | 1.93 |
| Dec-26 | 1.99 | 1.98 | 2.02 | 1.95 |
| Dec-29 | 1.96 | 1.94 | 2.05 | 1.91 |
| Dec-30 | 1.94 | 1.91 | 1.96 | 1.89 |
| Dec-31 | 1.91 | 1.95 | 1.99 | 1.91 |
| Jan-5 | 1.94 | 1.89 | 1.94 | 1.86 |
| Jan-6 | 1.88 | 1.87 | 1.93 | 1.87 |
| Jan-7 | 1.90 | 2.22 | 2.22 | 1.89 |
| Jan-8 | 2.23 | 2.22 | 2.29 | 2.13 |
| Jan-9 | 2.23 | 2.06 | 2.24 | 2.02 |
Nautilus Biotechnology, Inc. Earnings
Data Unavailable
Nautilus Biotechnology, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.00 per share.
* Nautilus Biotechnology, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.